No publication covers vaccine development as comprehensively as Vaccine Weekly.
Not only does Vaccine Weekly bring you more reports, but more coverage of every aspect of vaccine drug development, from drug candidate identification through launch and beyond.
Published weekly, each issue of Vaccine Weekly has more than 130 articles that cover drug development A-Z, including the nanotechnology involved in vaccine delivery systems, new vectors, monoclonal antibodies, recombinant fusion proteins, and important discoveries in genetics and cellular biology impacting vaccine research.
But important vaccine research news is only half the picture. Vaccine Weekly also provides key business intelligence regarding marketing, distribution, licensing, regulatory actions, personnel and funding for the pharmaceutical and biotech companies involved in vaccine research and manufacturing.
NewsRx editors collect coverage from more than 4,000 peer-reviewed journals, dozens of industry meetings, medical news wires, pharmaceutical and biotech company internet sites, purchased databases, and press releases.
Each article, usually no more than 500 words, is written to be an information-heavy, concise report of the pertinent facts, together with full references and citations for original source material. You get a fast, user-friendly read that keeps you on top of all the important vaccine-related developments for that week.
Vaccine Weekly is available in print or online at www.NewsRx.com. Email versions can be delivered directly to your desktop. Site licenses are also available for corporate use.
Combination print and email subscriptions are available, and all subscriptions come with online access to Vaccine Weekly's archives, which go back to 1995. See a sample issue here.
NewsRx first published Vaccine Weekly in 1988, and at the time, it was the first weekly publication dedicated solely to vaccine coverage. We stake our 20-plus year history as a publisher that it remains the best.
But don't take our word for it. Sign up for our six-week, no-risk free trial and see for yourself. Receive six issues of Vaccine Weekly, more than 700 articles, and see why it will become your indispensable tool for tracking vaccine news and developments.
Subscribe now and we'll give you $300 off our regular subscription price. You get the power of the most comprehensive vaccine coverage in the industry at a great discount.
Start today, and eliminate all those hours you normally spend scanning dozens of periodicals, websites, and other information sources. We've done it for you; we've got you covered.
|
2008